Angiolab, Inc. (XKON:251280)
South Korea
· Delayed Price · Currency is KRW
4,000.00
-90.00 (-2.20%)
At close: Aug 14, 2025, 3:30 PM KST
Angiolab Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2015 | FY 2014 |
| Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 |
| Revenue | 702.62 | 878.44 |
| Revenue Growth (YoY) | -20.02% | - |
| Cost of Revenue | 364.03 | 482.43 |
| Gross Profit | 338.6 | 396.01 |
| Selling, General & Admin | 528.36 | 402.34 |
| Research & Development | 277.19 | 189.44 |
| Other Operating Expenses | 17.33 | 12.82 |
| Operating Expenses | 1,055 | 772.36 |
| Operating Income | -716.07 | -376.36 |
| Interest Expense | -0.92 | -19.78 |
| Interest & Investment Income | 63.5 | 15.2 |
| Currency Exchange Gain (Loss) | 15.43 | 18.62 |
| Other Non Operating Income (Expenses) | -21.48 | 0.79 |
| EBT Excluding Unusual Items | -659.54 | -361.52 |
| Asset Writedown | -526.96 | - |
| Other Unusual Items | - | 11.21 |
| Pretax Income | -1,187 | -350.31 |
| Net Income | -1,187 | -350.31 |
| Net Income to Common | -1,187 | -350.31 |
| Shares Outstanding (Basic) | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 |
| Shares Change (YoY) | -0.09% | - |
| EPS (Basic) | -1356.00 | -400.00 |
| EPS (Diluted) | -1356.00 | -400.00 |
| Free Cash Flow | -105.3 | -182.39 |
| Free Cash Flow Per Share | -120.34 | -208.26 |
| Gross Margin | 48.19% | 45.08% |
| Operating Margin | -101.91% | -42.84% |
| Profit Margin | -168.87% | -39.88% |
| Free Cash Flow Margin | -14.99% | -20.76% |
| EBITDA | -483.63 | -224.34 |
| EBITDA Margin | -68.83% | -25.54% |
| D&A For EBITDA | 232.44 | 152.02 |
| EBIT | -716.07 | -376.36 |
| EBIT Margin | -101.91% | -42.84% |
| Advertising Expenses | 6.08 | 0.25 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.